Combined Use of a Novel Cardioplegic Formula With MPS ® Using the MiECC in Isolated CABG Versus OPCABG (OPCBAG)

University Hospital Basel

Status: Completed

Conditions: Complication of Extracorporeal Circulation; Complication of Coronary Artery Bypass Graft

Treatments: Procedure: CABG

Study type: Observational

Funder types: Other

Identifiers

NCT03609723

2018-00923 ch18reuthebuch2;

Details and patient eligibility

About

A patient group receiving a novel cardioplegic formula with MPS ® (Myocardial protection system) and using the MiECC (Minimal extracorporeal circulation system) when undergoing coronary artery bypass grafting is compared to a retrospective patient group undergoing Off-pump coronary artery bypass grafting.

Enrollment: 2,433 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• CABG using MPS® or OPCABG

Exclusion criteria

• use of other colloid solution than Cardioplexol ® for MPS®
• other inventions than CABG
• myocardial infarction <7 days before CABG
• patients denial of data use

Trial design

2,433 participants in 2 patient groups

MPS® in patients with CABG

Description:

Patients undergoing coronary artery bypass grafting with application of a myocardial protection system (MPS ®) and using a minimal extracorporeal circulation system (MiECC)

Treatment:

Procedure: CABG

OPCABG in patients with CABG

Description:

Patients undergoing coronary artery bypass grafting without use of a minimal extracorporeal circulation system (Off-pump coronary artery bypass grafting = OPCABG)

Treatment:

Procedure: CABG